Operating Lease, Right-of-Use Asset of Skye Bioscience, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Skye Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Skye Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $311,620, a 69% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $311,620 +$127,111 +69% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $355,427 +$152,440 +75% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $407,401 +$186,597 +85% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $449,864 +$211,881 +89% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $184,509 -$70,043 -28% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $202,987 -$67,566 -25% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $220,804 +$170,154 +336% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $237,983 +$166,792 +234% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $254,552 +$163,488 +180% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $270,553 +$160,249 +145% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $50,650 -$78,285 -61% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $71,191 -$75,781 -52% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 $91,064 -$73,609 -45% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $110,304 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $128,935 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $146,972 +$146,972 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $164,673 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q4 2020 $0 31 Dec 2020 10-K 28 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.